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Purpose: This study was designed to test the hypothesis that cardiac complications 
(myocardial infarction, congestive heart failure, fatal arrhythmias) are no longer the 
leading cause of death after elective aortic reconstructions. 
Methods: The medical records of all elective infrarenal aortic reconstructions performed 
between January 1982 and June 1994 were retrospectively reviewed. All perioperative 
deaths were analyzed to determine the canse of death and were compared with a subset of 
266 survivors to identify any associated preoperative or intraoperative factors. 
Results: Seven htmdred twenty-two aortic reconstructions were performed for aneurysmal 
or occlusive disease, and there were 44 deaths (overall mortality rate of 6.1%). The 
mortality rate after aortic reconstruction alone was 4.9% and increased with the addition 
of renal (8.9%, p = 0.16) or Iower extremity vascular procedures (15.8%, p = 0.01). 
Multisystem organ faihtre (MSOF) was the canse of death in 56.8% of the patients (3.5% 
overall mortality rate) followed by cardiac events in 25% (1.5% overall mortality rate). 
Visceral organ dys~mction was the most common cause of MSOF leading to death in 14 
patients (56.0%), and postoperative pneumonia was responsible for the fatal MSOF in 
nine patients (36.0%). Patient age, history of myocardial infarction/congestive heart 
failure, ejection fraction less than 50%, duration of operative time, and performance of
additional procedures were associated with increased operative mortality rates by 
multivariate analysis. 
Conclusions: MSOF, predominantly from visceral organ dysfimction, was the leading cause 
of death after elective infrarenal aortic reconstruction. The risk of MSOF and operative 
death increases with the complexity of the procedure and the number of comorbid 
conditions. (J VASC SURG 1995;22:287-94.) 
Previous seminal series on abdominal aortic 
reconstructions for aneurysmal disease reported that 
complications of coronary artery disease (myocardial 
infarction, fatal arrhythmias, congestive heart failure) 
were the leading cause of postoperative death} -a
Furthermore, Hertzer et al.4 reported that 60% of 
1000 patients had evidence of severe coronary artery 
disease (stenosis in at least one vessel > 70%) on 
routine preoperative coronary arteriography before 
all types of vascular econstruction. As a result of 
these findings, significant emphasis has been placed 
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on cardiac testing before aortic reconstructions. 
However, Taylor et al. 5 and Seeger et al. ó have 
recently reported low cardiac mortality rates in 
patients undergoing elective vascular econstmctive 
procedures and demonstrated that these results may 
be achievcd by use of limited preoperative cardiac 
testing. Despite this reduction in heart-related op- 
erative deaths, the overall operative mortahty rate 
after aortic reconstruction ranges from 3% in the 
bet-ter recent individual series 3,79 to 6% in two 
recently reported statewide series} °,11 This suggests 
that either these series havc not achieved the low rate 
of postoperative heart-related eath reported by 
Taylor et aL s and Seeger et al.6 or, alternatively, 
postoperafive complications other than cardiac 
evcnts are now the primary cause of death after aortic 
reconstruction. This study was undertaken to define 
the cause of operative death after elective infrarenal 
aortic rcconstruction i a large number of patients 
treated at an institution reported to have a low rate of 
postoperative cardiac complications ó and to deter- 
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mine whether preoperative risk factors for non-heart- 
related eaths could be identified. 
MATERIAL AND METHODS 
Patients and data collection. A medical data- 
base was constructed after retrospecfive r view of 
operative notes, departmental mortality/morbidity 
records, and weekly preoperative evaluation data 
sheets from 722 consecutive patients undergoing 
elective infrarenal aortic reconstruction between 
January 1, 1982 and June 30, 1994, at the University 
of Florida College of Medicine. Data collected from 
this review included indications for surgical recon- 
struction, operative procedures performed, postop- 
erative complications, and postoperative d aths. The 
complete medical record of all 44 patients who died 
after aortic reconstructive procedures was then re- 
viewed, and a second more comprehensive database 
was constructed including patient demographics, 
preoperative risk factors, operative parameters, post- 
operative course, and cause of death. Similar data 
were collected from a randomly selected subset of 
266 patients whose complete medical record was 
available for review to identify preoperative, intraop- 
erative, or postoperative risk factors associated with 
death. 
Preoperative patient evaluation. Clinical risk 
factors for coronary atherosclerosis and symptoms of 
heart disease were evaluated in all patients. Electro- 
cardiograms were obtained in all patients, and most 
had left ventricular evaluation by either gated blood 
pool scanning or echocardiography. Selected patients 
were referred for preoperative cardiac atheterization 
on the basis of symptoms and left ventricular fimction 
assessment. In addition, asubset of 135 patients were 
entered into a prospective evaluation ofpreoperative 
stress-thallium cardiac imaging, 6 and those with 
positive thallium study results (redistribution  hte 
images in at least one view) were referred for 
coronary arteriography. On the basis of the results of 
coronary arteriography, selected patients underwent 
cardiac revascularization with either balloon angio- 
plasty or coronary artery bypass grafting. All patients 
also underwent s andard pulmonary function testing 
with resting arterial blood gases, and routine clinical 
laboratory tests for renal, hepatic, and hematologic 
function were obtained. Last, all patients underwent 
standard aortography with lower extremity runoff. 
Operative and postoperative eare. Four hun- 
dred sixteen patients (57.6%) underwent aortic 
reconstruction for aneurysmal disease, 283 (39.2%) 
for aortoiliac occlusive disease and 24 (3.3%) for a 
combination of aneurysmal nd occlusive disease. 
Aortic reconstruction alone was performed in 459 
patients, whereas additional procedures included 
inferior mesenteric artery (IMA) reimplantation i  
144, internal iliac artery (IIA) reconstruction i  6, 
renal artery repair in 56, and a concomitant lower 
extremity procedure (revascularization, thromboem- 
bolectomy, amputation) in 57. All aortic reconstruc- 
tive procedures were performed with use of general 
anesthetic, whereas adjunctive pidural narcotic in- 
fusion was used in select patients. The aortic recon- 
structions were performed with standard techniques. 
Proximal aortic control was obtained below the renal 
arteries in most cases, whereas uprarenal control 
(caudal to the superior mesenteric artery) was re- 
quired for all juxtarenal neurysms and for select renal 
revascularizations. Balloon-tipped, thermodilution 
pulmonary artery catheters were used in all patients 
with reduced left ventricular function and those 
considered at increased risk for cardiac, pulmonary, 
or renal artery complicätions. All patients were 
monitored after operation in the intensive care unit 
for at least 24 hours. Serial cardiac enzymes were 
obtained at 8-hour intervals during the initial 24- 
hour postoperative p riod. 
Determination of postoperative organ dys- 
funetion. The criteria used to determine organ 
system failure are shown in Table I and were modified 
from those of Suchyta et al.12 MSOF was defined as 
greater than one organ system failure. 
Analysis. Stafistical analyses were performed by 
the Biostatistics Consulting Laboratory at the Uni- 
versity of Florida College of Medicine. The influence 
of additional procedures on the mortality rate and 
cause of death was compared by use of chi-square 
analysis. The preoperative risk and operative param- 
eters for the pafients who died and the subset of 266 
survivors were compared by univariate analysis with 
chi-square änalysis, Fisher's exact test, or unpaired 
Student testing where appropriate. The simulta- 
neous influence of the preoperative and operative 
factors on operative mortality rates were assessed 
with multivariate logistic modeling. The multivariate 
analysis was performed two separate ways. First, the 
subset of survivors and nonsurvivors (n = 177) in 
which complete preoperative and operative data were 
available for all variables was analyzed. Second, all 
patients (n = 310, survivors and nonsurvivors) were 
examined by use of the variables (additional proce- 
dures, hypertension, myocardial infarction, angina, 
congestive heart failure, renal insufficiency, smoking, 
diabetes mellitus) that had complete data, and the 
influence of the remaining variables (pulmonary 
function, operative time, aortic clamp time, ejection 
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Table I. Criteria for organ failure 
Organ Definition 
Respiratory 
Renal 
Cardiovascular 
Coagulation 
Hepatic 
Central ner¢ous ystem 
Gastrointestinal 
Immunologic 
Ventilator dependence -> 7 days 
Creatinine _> 3.5 mg/dl or patient requiring dialysis or urine output < 25 ml/h for 24 hr 
Cardiac index < 1.8 L/min/m 2or systolic blood pressure < 90 mm Hg or pressor drugs or arterial- 
venous oxygen difference > 7.0 ml O2/dl 
Platelet count < 60,000 and prothrombin time or partial thromboplastin time > 1.5 times the control 
Bilirubin > 5 mg/dl and prothrombin time or partial thromboplastin time > 1.5 times the control 
Glasgow coma score < 8 for 3 days 
Pancreatitis causing shock or rupture/necrotic/ischemic viscus or gastrointestinal hemorrhage r quiring 
more than 2 units of packed red blood cells 
Patient receiving prednisone or the equivalent of 50 mg/day for at least seven days or prednisone or the 
equivalent >_ 20 mg/day for at least one month or other known immunosuppressive agent or patient 
with AIDS 
AIDS, Acquired immune deficiency syndrome. 
fraction, estimated blood loss) in which complete 
data were not available was determined by individual 
addition to the model. Results are expressed as 
mean ___ standard deviation, and p values < 0.05 
were considered to be significant. 
RESULTS 
Forty-four patients (6.1%) died after elective 
infrarenal aortic reconstruction, and an additional 
152 (21.0%) experienced nonfatal postoperative 
complications. One half of the patients who died 
required reoperation for treatment of a complication, 
and 25% required more than one reoperative proce- 
dure. The mortality ratc did not vary with the 
indication for aortic reconstruction (aneurysmal dis- 
ease, 6.3%; occlusive disease, 5.7%; combined 
aneurysm~/occlusive, 8.3%). However, the mortal- 
ity rate was influenced significantly by whether 
additional procedures were performed in conjunction 
with the aortic reconstruction. The mortality rate 
after aortic reconstruction alone or with IMA reim- 
plantation or IIA revascularization was 4.9% (Table 
II), and addition of the IMA or IIA revascularization 
did not increase the risk of death (mortality rate for 
aortic reconstruction plus IMA or IIA repalr of 
2.0%). In contrast, the mortality rate after aortic 
reconstruction plus renal revascularization was 
8.9% (p = 0.16 vs the mortality rate of aortic 
reconstruction ± IMA or IIA repair) and after si- 
multaneous aortic reconstruction and lower extrem- 
ity arterial procedures was 15.8% (p = 0.01 vs the 
mortality rate ofaortic reconstruction + IMA or IIA 
repair). Twenty of the 57 (35.7%) simultaneous 
aortic and lower extremity procedures were per- 
formed unexpectedly for acute ischemia, whereas the 
remaining were planned. 
MSOF was the leading cause of death after aortic 
reconstmction a d accounted for 25 of the 44 deaths 
Table II. Influence of additional 
procedures on operative mortality 
Æortality 
Procedure Cases Death rate 
Aorta _+ IMA/IIA revascu- 609 30 4.9% 
larization 
Renal revascularization 56 5 8.9% 
Lower extremity procedure 57 9 15.8%* 
*Significant, p = 0.01. 
(Table III, overall MSOF mortality rate of 3.5%). 
Cardiac complications were the cause of death in 11 
patients, with death resulting from myocardial in- 
farction in nine and uncorrectable ventricular ar- 
rhythmia in two (overall cardiac mortality rate of 
1.5%). Hemorrhage was the cause of death in three 
patients, with one patient dying after pnlmonary 
artery rupture from a catheter injury and two dying 
during operation with uncorrectabte coagulopathies 
(one with a preoperative coagulopathy from alco- 
holic cirrhosis). Two patients died of primary res- 
piratory failure, one patient died of hyperkalemia 
caused by acute renal insufficiency after intraop- 
erative lower extremity thrombosis, and one patient 
died of a stroke. An additional patient with end- 
stage renal disease refused further hemodialysis after 
an aortobifemoral bypass and died. Fifteen of the 
30 deaths (50.0%) after aortic reconstruction + 
IMA or 11A repair, four offive (80.0%) deaths after 
aortic reconstruction plus renal revascularization, 
and five of nine (55.6%) deaths after aortic recon- 
struction plus lower extremity procedures resulted 
from MSOF (p = ns). 
Visceral organ dysfunction was the most com- 
mon cause of MSOF and occurred in 14 patients 
(Table IV). The initiating event for MSOF was liver 
failure in six patients, colon or small bowel infarction 
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Table III. Cause of death after 
aortic reconstruction 
Cause of death Cases % of total deaths 
MSOF 25 56.8 
Cardiac 11 25.0 
Hemorrhage 3 6.8 
Respiratory 2 4.5 
Extremity ischemia 1 2.3 
Stroke 1 2.3 
Refusal of therapy 1 2.3 
Table IV. Cause of MSOF 
Cause Cases % 
Visceral organ dysfunction 14 56.0 
Postoperative pneumonia 9 36.0 
Aortoenteric fismla 1 4.0 
Extremity ischemia 1 4.0 
in four patients, pancreatitis n two patients, diver- 
ticulitis with a sigmoid colon perforation in one 
patient, and upper gastrointestinal bleeding in orte 
patient. Alcohol abuse (t-wo of six), a history ofviral 
hepatitis (one ofsix), and cirrhosis (three ofsix) were 
identified either before or during operation i  the six 
patients who had development of liver failure leading 
to MSOF. Left or sigmoid colon infarction occurred 
in two patients in whom the IMA was found to be 
occluded uring operation and thus could not be 
repaired and in one patient in whom a patent IMA 
was ligated. Right colon and small bowel infarction 
developed after operation in one patient after an 
aortobifemoral bypass with an end-to-side proximal 
aortic graft anastomosis and reimplantation of the 
IMA. Postoperative pneumonia complicated by as- 
piration (two patients) or adult respiratory distress 
syndrome (two patients) was the cause of MSOF in 
nine patients, whereas an acute aortoenteric fistula 
and uncorrectable lower extremity ischemia were the 
causes in the remaining two patients. Sepsis was 
associated with the initiating event of MSOF in 16 
patients (66.6%), whereas eight patients (33.3%) 
had development ofMSOF without initial evidence 
of sepsis. Seventy-four percent of patients who died 
ofMSOF required at least one reoperative procedure 
for treatment ofa complication. At the time of death, 
patients with MSOF had an average of 4.25 systems 
that had failed. Respiratory failure (100%), kidney 
failure (91.7%), and cardiovascular failure (75%) 
were present in most patients dying of MSOF, 
whereas gastrointestinal (41.7%) and liver failure 
(33.3%) were also common. Of the patients who 
satisfied the criteria for cardiovascular failure at the 
time of death from MSOF, one qualified on the basis 
ofa low cardiac index (< 1.8 L/min/m2), whereas the 
remainder qualified on the basis of the need for 
pressor support o maintain asystolic blood pressure 
greater than 90 mm Hg. 
The mean age and incidence of preexisting kidney 
disease were significantly higher by univariate anal- 
ysis in patients who died after undergoing aortic 
reconstruction ascompared with the patients who 
survived (Table V). In addition, both a history of 
heart disease as indicated by a previous myocardial 
infarction, angina, or congestive heart failure and an 
abnormal ejection fraction (<55%) were more 
common in nonsurvivors. Surprisingly, the incidence 
of smoking and preoperative pulmonary dysfunction 
wert similar in both survivors and nonsurvivors. 
Patients who died also underwent longer operations 
with a higher incidence of additional procedures than 
patients who survived. Patient age, history of myo- 
cardial infarction, and history of congestive heart 
failure were found to predict death by multivariate 
analysis of the patients or variables with complete 
data, whereas ejection fraction < 55%, duration of 
operative procedure, and performance of additional 
procedures were all found to be associated with 
increased mortality rates when variables with incom- 
plete data were added stepwise to the logistic 
regression model. 
DISCUSSION 
Multisystem organ failure was the leading cause 
of death after elective infrarenal ortic reconstruction 
and accounted for greater than twice the number of 
deaths as heart-related vents. Visceral organ dys- 
function appeared to be the initiating event for the 
MSOF in most of the cases. The overall operative 
mortality rate increased with the complexity of the 
procedure and with the severity of the underlying 
comorbid medical conditions. 
Cardiac events have historically been reported to 
be the leading cause of death after elective infrarenal 
aortic reconstruction (Table VI). In 1964 Deßakey et 
al. 1 reviewed 1719 patients tmdergoing abdominal 
aortic aneurysm repair and found a 30-day mortality 
rate of 9%, with most of the deaths being due to 
cardiac events. In 1975 Thompson et al. a reviewed 
108 patients undergoing abdominal aortic aneurys- 
mectomy and reported a 5.5% mortality rate, with 
five of six deaths resulting from heart-related causes. 
Similarly, in 1989 Johnston 13 reported results from a 
prospective, multicenter study of 666 patients un- 
dergoing repair of nonruptured abdominal aortic 
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Table V. Comparison of preoperative and operative parameters 
Preoperative/operative parameter Survivors Nonsurvivors p Value 
Age 64.7 _+ 8.1 69.0 -+ 9.1 p < 0.01 
Noncardiac 
Hypertension 60.1% 75.0% p = 0.06 
Renal insufficiency 17.7% 53.7% p < 0.01 
Diabetess mellims 11.6% 20.5% p = 0.11 
Smoking 89.0% 93.2% p = 0.78 
Abnorrnal PFT 61.5% 65.4% p = 0.72 
Cardiac 
Myocardial infarction 26.3% 47.7% p < 0.01 
Angina 10.5% 25.0% p < 0.01 
Congestive heart failure 5.6% 25.0% p < 0.01 
Ejection fraction < 55% 22.8% 53.6% p < 0.01 
Operative 
Duration of procedure 5.7 _+ 2.0 7.7 + 2.8 p < 0.01 
Additionat procedure 15.5% 31.8% p < 0.01 
Aortic cross-clamp time 70.0 + 32.2 80.3 _+ 38.8 p = 0.23 
Estimated blood loss 1908 + 1444 2262 + 1638 p = 0.17 
PFT, Pulmonary function test. 
Table VI. Collective series of abdominal aortic reconstructions 
Author Patients A/lortality rate Cardiac nortality rate 
DeBakey et al)* 1719 9.0% Majority 
Szilag-yi et al.3t 401 14.7% 7.0% 
Thompson et al? 108 5.5% 4.6% 
johnston 13 666 4.8% 3.3% 
Sedwitz et al.~S 109 0% 0% 
Golden et al. 18 500 1.6% 0.4% 
Taylor et al. 5 2855 0% 0% 
Cambria et al)  6 202 2.0% 0.5% 
Lachapelle t al. 17 146 4.8% 3.4% 
Baron et al. 14 457 4.4% 2.2% 
*Elective 
tElective 
SElective 
and rupmred aneurysms. 
and symptomatic aneurysms. 
general vascular procedures in addition to aortic reconstructions. 
aneurysms and found an operative mortality rate of 
4.8% and a heart-related mortality rate of 3.3%. 
However, more recently, Baron et al. 14 reported an 
instimtional series of 457 consecutive abdominal 
aortic aneurysm repairs with an overall mortality rate 
of 4.4%, in which only one half of the deaths were 
due to heart-related causes. Several other recent 
smdies ~'15-18 have reported operative mortality rates 
of 0% to 4.8%, and cardiac events have been respon- 
sible for the majority of the deaths in only one 
smdy. The results of these more recent series are 
similar to the 4.9% mortality rate (aortic reconstruc- 
tion _+ IMA or IIA repair) and the 1.5% overall 
cardiac mortality rate reported in this smdy. This 
suggests that the cardiac mortality rate has de- 
clined more than the overall mortality rate and is no 
longer the primary cause of death after aortic recon- 
struction. 
The overall operative mortality rate and the high 
incidence of fatal MSOF reported in this analysis 
appear to result largely from performing more 
complex procedures in older, sicker patients. This is 
particularly evident for patients undergoing aortic 
reconstruction with concomitant renal or lower 
extremity procedures. Patient age, the severity of 
disease (Acute Physiology and Chronic Health 
Evaluation [APACHE II] Score), and a diagnosis of 
sepsis at the time of intensive care unit admission 
have previously been identified as risk factors for the 
development ofMSOF. 19 In addition, Bickerstaff et 
al. 2° have reported that performance of a second 
procedure concomitant with aortic reconstruction 
increased the operative mortality rate, although the 
increase did not reach statistical significance. Further- 
more, the reported operative mortality rates for 
simultaneous aortic reconstruction and renal or 
visceral revascularization have ranged from 3.0% to 
10.3%, 212s and Amip et al. 23 reported that all three 
of their operative deaths after aortic reconstruction 
and visccral revascularization wcre due to MSOF. 
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The visceral organ dysfunction that contributed 
to the fatal MSOF did not appear to result from 
primary heart failure. Admittedly, visceral ischemia 
was responsible for the four cases of colonic/small 
bowel infarction and could have potcntially contrib- 
uted to the other cäses. Furthermore, cardiovascular 
system failurc was seen in 75% of the patients who 
died in MSOF. All but one of these patients atisfied 
the criteria for cardiovascular failure on the basis of 
the requirements for vasopressor support, and ad- 
mittedly this support likely limited visceral perfusion. 
Howevcr, the associated cardiac indexes in these cases 
were normal or elevated, and thus primary cardiac 
failure did not appear to be contributory. The 
cardiovascular system failure appeared to be caused 
by the underlying problem and was frequently a near- 
terminal event. 
The visceral organ dysfunction that led to the fatal 
MSOF in this smdy was neither predictable nor 
preventable in most of the cases. Colonic infarction 
and death from MSOF occurred in three patients 
despite the IMA being chronically occluded in t-wo of 
these cases and reimplanted in the third. All patent 
IMAs were routinely reimplanted throughout most 
of the study period on the basis of the report from 
Seeger et al. 24 that documented an associated reduc- 
tion in operative mortality rate from colonic infarc- 
tion. Pancreatitis and fatal MSOF developed in two 
patients despite careful retraction and no evidcnce of 
injury to the gland during the procedure. Further- 
more, liver failure developed in six patients despite 
the lack ofpreoperative biochemical bnormalities or
stigmata of liver disease on physical examination. 
This emphasizes the current limitations of the pre- 
operative hepatic biochemical tests and supports 
more invasive preoperative testing in patients be- 
lieved to have compromised hepatic function. 
Progression to MSOF is generally believed to 
result from sepsis and to be mediated by cytokines. 25 
However, a septic source was identified in only two 
thirds of the patients who died of MSOF. The term 
systemic inflammatory response syndrome has recently 
bcen coined to describe the clinical presentation 
consistent with sepsis but lacking a confirmed infec- 
tious source. 26 The underlying mechanism is pre- 
sumed to be infectious, despite the lack of a source, 
and appears to be mediated through macrophage- 
derived cytokines. 2ö-28 Mternatively, visceral organ 
ischemia could be responsible for macrophage acti- 
ration leading to cytokine release and could account 
for progression to MSOF. Animal studies have 
shown that distal organ dysfunction, partieularly 
pulmonary, can occur after acute mesentcric isch- 
emia and reperfusion. 29,3° Furthermore, Harward et 
al.31 recently reported that revascularization of 
chronically ischemic bowel leads to a significant risk 
of postoperative multiorgan dysfunction. However, 
the relationship between intraoperative and post- 
operative mcsenteric ischemia and the progression 
to MSOF in this study is purely speculative. Re- 
gardlcss, it merits additional investigation both 
because it is potentially treatable and because the 
new anticytokine agents may potentially prevent he 
distant organ complications. 
The results of this study have influenced our 
practice. The low cardiac mortality rate associated 
with electivc aortic reconstructions supports our 
selective preoperative cardiac evaluation. Addition- 
ally, the study further demonstrates the safety of 
reimplanting the IMA. Combined aortic and lower 
extremity procedures for severe multilevel occlusive 
disease are now avoided whenever possible. If 
simultaneous inflow/outflow reconstructions are nec- 
essary, a combined extraanatomic aortic bypass and 
lower extremity revascularization is performed. Un- 
fortunatcly, unplanned combined procedures are 
occasionally necessary and were required for intra- 
operative vidence of acute extremity ischemia fter 
aortic reconstruction in one third of the total number 
of combined cases. Greater emphasis has been placed 
on the preoperative identification of hepatic insuffi- 
ciency. Furthermore, patients with hepatic insuffi- 
ciency and severe aortoiliac occlusive disease are 
considered for extraanatomic bypass. 
In conclusion, MSOF seems to be replacing 
cardiac events as the leading cause of death after 
elective, infrarenal aortic reconstruction. This 
change is related to both the reduction of cardiac 
mortality rates and the performance of more com- 
plex procedures in sicker patients. Although visceral 
organ dysfunction was the leading cause of MSOF, 
it is rarely predictable from the preoperative evalu- 
ation. Further reduction of the operative mortality 
rate in this patient population is contingent on 
better identification of the predisposing factors for 
MSOF, continued careful selection of patients in 
whom additional reconstructive procedures are per- 
formed in conjunction with the aortic reconstruc- 
tion, and potentially arrest of the progression to 
MSOF. 
We thank Ms. Nina Klingman for her technical 
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DISCUSSION 
Dr. Larry H. Hollier (Glasgow, United Kingdom). 
The central theme of this report is that perhaps death from 
myocardial infarction is decreasing as a result of better 
diagnosis and treatment ofcoronary artery disease and that 
now MSOF is becoming the most common cause of 
postoperative d ath. In my opinion the authors have failed 
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to prove their hypothesis. In fact I think they chose the 
wrong hypothesis. In the early 1980s most major series 
reported mortality rates of less than 3%, and the rate of 
death from heart-related causes was around 1.5% to 2%. 
Although the authors' heart-related mortality rate is 1.5%, 
the overall mortality ra~e is 6.1%. Additionally there did 
not appear to be any significant change in the relative 
incidence of deaths from myocardial infarction and MSOF 
over this 12-year period of the review. The major difference 
in this report is the high incidence of MSOF throughout 
the entire time period. It is this issue that I believe requires 
the greatest discussion. 
First, the operative procedure times in the cases 
averaged almost 6 hours in survivors and more than 71/2 in 
nonsurvivors. What was the time involved in the combined 
procedures, particularly when lower extremity revascular- 
ization was performed, which appeared to have the highest 
mortality rate? 
Aortic cross-clamp tirne was more than 1 hour in 
survivors and more than 1 hour 20 minutes in nonsurvi- 
vors. This appears rather prolonged. Do you believe that 
this extended operative xcursion had any influence on the 
higher incidence of multisystem organ failure? 
In my experience MSOF after aortic surgery is generally 
limited to those patients requiring large amounts of blood 
and crystalloid fluids or those who undergo suprarenal 
aortic cross-damping. The data summaries in the article 
note the high volume of blood given in nonsurvivors, 
specifically more than 41/2 units of blood with a standard 
deviation of -+ 3 units of blood. What was the average 
volnme of blood given to those dying specifically of 
MSOF? Also, did any of the patients with MSOF undergo 
suprarenal aortic clamping during the procedure? 
Why is there such a high incidence of MSOF? It is my 
impression that the authors are seeing a very high incidence 
of sick people, and I think they are taking an aggressive 
approach. I do not think that we should ihrer that the 
results that the anthors achieved are due to inadequate 
surgical expertise but rather a general approach across the 
country of tackling the more difficult cases. I would 
caution, however, that we not at-tribute the results to any 
perceived ecrease in heart-related deaths. 
Dr. Thomas S. Huber. We have not separated out the 
patients who undergo lower extremity procedures as far as 
the operative times. Clearly they had increased operative 
times, although I can't give you a specific number for that. 
Of the patients dying of MSOF, only one of them 
mlderwent suprarenal cross-clamping. We particularly 
excluded any patients with suprarenal neurysms from the 
study, and thus these results reflect only infrarenal repairs. 
All hut one of the nonsurvivors was repaired with infrarenal 
cross-clamp. 
We certainly agree with Dr. Hollier that our mortality 
rate in the subgroups of renal revascularizations in the 
lower extremity procedures reflect a more complex proce- 
dure and patients who are indeed sicker. 
Dr. Norman Hertzer (Cleveland, Ohio). I agree with 
Dr. Hollier that we now seem to be tackling a tougher 
group of patients, and this appears to be especially true 
among those with aortoiliac occlusive disease. During the 
past few years at the Cleveland Clinic, the operative 
mortality rate in these patients has exceeded the risk for 
elective repair of infrarenal aortic aneurysms. This his- 
torically had not been the case, and I wonder whether 
at least one explanation might be that so many patients 
at good risk with short-segment disease currently undergo 
percutaneous transluminal ngioplasty rather than surgical 
treatment. What was the mortality rate for the patients 
in your series who had occlusive disease? Did it seem to 
climb in comparison to aortic aneurysms after the in- 
troduction of iliac percutaneous transluminal coronary 
angioplasty? 
Dr. Huber. Actually the mortality rate for both 
aneurysmal and occlusive disease were almost identical, 
6.3 % for the patients with aneurysmal disease and 5.7% for 
the patient with occlusive disease. 
